14/10/2026 - General information
The International Society of Paediatric Oncology (SIOP) has awarded the Odile Schweisguth Award to research on Ewing sarcoma carried out by Dr Irene Cuervas, a researcher at the Hospital del Mar Research Institute and the Sant Joan de Déu Research Institute (IRSJD). The study was co-led by Dr Inmaculada Hernández-Muñoz, a researcher with the Dermatological Inflammatory and Neoplastic Diseases Research Group at HMRIB, and Dr Jaume Mora, head of the Sarcoma and Neuroblastoma Research Group at IRSJD, and was conducted in collaboration with the Centre for Genomic Regulation (CRG).
13/10/2026 - General information
Research in the field of frailty and kidney transplantation, led by the Nephrology and Physical Medicine and Rehabilitation Departments at Hospital del Mar and researchers from the Hospital del Mar Research Institute, has received the Nephrology Research Award at the Íñigo Álvarez de Toledo Awards for Nephrology Research, presented by the Spanish Kidney Foundation. The award jury, made up of 22 experts in nephrology, research and business, granted two awards: one for nephrology and another for nephrology nursing, which, in this edition, was shared by two projects.
07/10/2026 - Press release
The GLP-1 receptor is a protein that responds to GLP-1, a naturally occurring hormone that regulates blood sugar levels and feelings of satiety. It is therefore the target of some of the most advanced and widely used treatments currently available for type 2 diabetes and obesity, such as Ozempic. For this reason, understanding how the function of this receptor may vary depending on genetic changes affecting it is particularly important. Individuals can naturally carry different genetic variants of the GLP-1 receptor, known as GLP1R variants. The individual risk of developing type 2 diabetes and variability in response to treatment may differ depending on the presence of a particular variant.
01/10/2026 - General information
Dr Sara Mederos, coordinator of the Neural Computation Laboratory at the Hospital del Mar Research Institute (HMRIB), is one of the researchers selected in the twelfth edition of the BBVA Foundation Leonardo Grants. Her project, 'Reorganization of Hippocampal-Prefrontal Learning Across Pregnancy', is one of 59 selected from nearly 1,900 proposals submitted. The project led by Dr Mederos aims to deepen our understanding of how neural circuits reorganise during pregnancy and the postpartum period. The research will focus on circuits involving the hippocampus and the prefrontal cortex, two brain regions that work together to build and update memories, guide decision-making and adapt behaviour to changes in the environment. The proposal was selected in the field of Biology and Medicine, one of the eleven areas covered by the Leonardo Grants.
Més informació "BBVA Foundation Leonardo Grant awarded to Dr Sara Mederos"
29/09/2026 - General information
The next Saturday 3 October marks a new edition of the PRBB Open Day. Once again, the building will open its doors to the public to discover first-hand the research carried out there, visit laboratories and scientific services, and meet the people who work there. Throughout the morning, from 10.00 am to 2.00 pm, professionals from the different PRBB research centres will share their day-to-day work and bring science closer to the public through a range of activities and guided tours. This year, OpenPRBB is placing a special focus on guided tours, offering an opportunity to access spaces that are not usually open to the public, discover one of Barcelona's major scientific infrastructures, and see how research is carried out from the inside.
Més informació "OpenPRBB 2026: on Saturday 3 October, experience science up close"
22/09/2026 - General information
Dr Anna Bigas, head of the Stem Cells and Cancer Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has joined the Board of Trustees of the Scientific Foundation of the Spanish Association Against Cancer as a scientific trustee. Her appointment took effect at the foundation's Board meeting held in Madrid on 17 September. Dr Bigas joins a select group of scientists who help guide the foundation's decisions regarding the selection of projects for funding and the definition of its main research priorities. "It is an honour to contribute to ensuring that cancer research is the best it can be," she explains. "Joining this Board of Trustees gives me the opportunity to draw on my experience as a researcher to help support high-quality cancer science and ensure that it reaches patients sooner," she adds.
21/09/2026 - General information
Alzheimer's research has reached a pivotal moment. Advances made in recent years point towards a new era in the diagnosis and treatment of the disease, one of the leading causes of dementia worldwide, affecting more than 800,000 people in Spain alone. To examine where we are now and where the field is heading, The Lancet has published an in-depth Seminar article aimed at medical students and healthcare professionals who are not specialists in this area. Among the seven international experts selected to prepare the article is Dr Marc Suárez-Calvet, from the Barcelona Brain Health Center (BBHC) at Hospital del Mar, the Hospital del Mar Research Institute and the Barcelonaβeta Brain Research Center of the Pasqual Maragall Foundation. Below, he outlines the main conclusions.
Més informació "A new era in the history of Alzheimer's disease"
10/09/2026 - General information
The ReTune-AD project, led by Dr Manuel Valero, coordinator of the Neural Computation Laboratory at the Hospital del Mar Research Institute (HMRIB), in collaboration with Dr Javier Márquez-Ruiz from Pablo de Olavide University, has been selected to receive funding through the Pasqual Maragall Researchers Programme 2025, organised by the Pasqual Maragall Foundation. The research will receive up to €800,000 in funding to support its progress. The programme funds research projects of excellence focusing on Alzheimer's disease and other age-related neurodegenerative diseases.
Més informació "The Pasqual Maragall Foundation will fund a project led by Dr Manuel Valero"
09/09/2026 - Press release
This technique identifies tumour mutations for which treatments are available, showing a high level of concordance with the analysis of tumour tissue samples. This makes it a particularly useful alternative when there is insufficient tissue available to carry out comprehensive molecular profiling of the tumour. Published in Clinical Cancer Research, the study analyses the largest cohort described to date, comprising nearly 11,000 patients, and validates the findings in an independent cohort of 126 patients with biliary tract cancer from nine hospitals across Spain.
04/09/2026 - Institutional news
The European Research Council (ERC) has selected a project led by Dr Sara Mederos, head of the Neural Computation Laboratory at the Hospital del Mar Research Institute (HMRIB), to receive an ERC Starting Grant worth almost €2.5 million. The review panel described her proposal as conceptually pioneering and well grounded.These grants are aimed at outstanding researchers with between two and seven years of postdoctoral experience. They usually provide €1.5 million in funding, with the possibility of requesting additional support, as in this case, to carry out high-level research projects.
Més informació "Sara Mederos receives an ERC Starting Grant"
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
